-
Diagnostics World | Researchers at Dana-Farber Cancer Institute and Massachusetts Institute of Technology have developed a new tool, based on artificial intelligence, that predicts the likely site of formation for cancer of unknown primary (CUP) tumors.
Oct 31, 2023
-
Diagnostics World | Mayo Clinic and Oxford Nanopore Technologies teams up in a multi-year joint development collaboration to help improve patient care, including some of the hardest-to-characterize conditions and sequencing DNA; Walgreens and the Cardiovascular Research Foundation (CRF) collaborates to drive the PREVUE-VALVE study, which will help pave the way for the development of new therapies and tools for VHD detection and diagnosis; Genialis announces a new data-sharing collaboration with Cancer Research Horizons to better predict responses to KRAS inhibitors, immunotherapies, and other emerging classes of therapeutics; and more.
Oct 26, 2023
-
Diagnostics World | bioMérieux further invests in Oxford Nanopore to expand in vitro diagnostics production; Harbinger Health trials blood-based cancer screening platform; HHS funds behavioral health services and HIV prevention for underserved populations; and more.
Oct 25, 2023